Navigation Links
Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer
Date:11/11/2010

ctive for larger tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer.

About ThermoDox® and the Phase III HEAT StudyThermoDox® is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.  In the HEAT study, ThermoDox® is administered intravenously in combination with RFA.  Localized mild hyperthermia (39.5-42 degrees Celsius) created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially in a targeted tumor.

For primary liver cancer, ThermoDox® is being evaluated in a 600 patient global Phase III study at 76 clinical sites under an FDA Special Protocol Assessment. The study is designed to evaluate the efficacy of ThermoDox® in combination with RFA when compared to patients who receive RFA alone as the control. The primary endpoint for the study is progression-free survival (PFS) with a secondary confirmatory endpoint of overall survival.  A pre-planned, unblinded interim efficacy analysis will be performed by the independent Data Monitoring Committee when enrollment in the trial is complete and 190 PFS events are realized in the study population.  Additional information on the Company's ThermoDox® clinical studies may be found at http://www.clinicaltrials.gov

About CelsionCelsion is a leading oncology company dedicated to the development and commercialization of innovative cancer drugs including tumor-targeting treatments using focused heat energy in combination wit
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Celsion Announces ThermoDoxs Prominence in Abstracts Presented at the 2nd International MR-Guided Ultrasound Symposium
2. Data Monitoring Committee Unanimously Recommends Continuation of Celsions Phase III ThermoDox® HEAT Study to Treat Primary Liver Cancer
3. Celsion Receives SBIR Grant To Expand Its Technology Platform
4. Celsion Receives Fast Track Designation for ThermoDox® Development Program to Treat Primary Liver Cancer
5. Celsion Announces CFO Departure
6. Stereotaxis Receives Commitment to Increase and Extend Credit Facility
7. Prolia™ (denosumab) Receives Best New Drug Honor at Scrip Awards
8. CMUs Bone Tissue Engineering Center Receives Defense Department Research Grant to Help Injured Soldiers
9. AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
10. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
11. DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Therapeutics, Inc. (NASDAQ: SRNE ; Sorrento) today announced ... Officer and Executive Vice President. Mr. Singh died suddenly and ... "Sorrento is deeply saddened and shocked by the loss of ... Amar,s family and friends," said Henry Ji , Ph.D., ... Singh joined Sorrento in January 2014 from Synta Pharmaceuticals, where ...
(Date:7/31/2014)... 2014 IRIDEX Corporation (Nasdaq: IRIX ) ... months ended June 28, 2014.  , Revenues were ... from $9.2 million in the 2013 second quarter and up ... Revenues for the first six months of 2014 were $20.9 ... months of last year. , Gross margin for the ...
(Date:7/31/2014)... Tandem Diabetes Care®, Inc. (NASDAQ: TNDM ... Insulin Pump, today reported its financial results for the quarter ... second quarter of 2014 to the same period of 2013: ... $5.5 million , t:slim Pump shipments grew 64 percent ... six months ended June 30, 2014 to the same period ...
Breaking Medicine Technology:Sorrento Announces the Unexpected Death of its Chief Business Officer 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 2IRIDEX Reports 2014 Second Quarter, Six-Month Results 3IRIDEX Reports 2014 Second Quarter, Six-Month Results 4IRIDEX Reports 2014 Second Quarter, Six-Month Results 5IRIDEX Reports 2014 Second Quarter, Six-Month Results 6IRIDEX Reports 2014 Second Quarter, Six-Month Results 7Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 2Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 3Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 4Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 5Tandem Diabetes Care Reports Second Quarter 2014 Financial Results 6
... WASHINGTON, Sept. 15 A home medical equipment provider ... "competitive" bidding program for durable medical equipment and services. ... and wound care specialist at Allcare Medical, in Sayreville, ... on Health that the bidding program, as designed by ...
... Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and... -- MINNEAPOLIS, Minnesota, September 15, ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 2Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 3Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 4Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 5Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 6Homecare Provider Testifies on Downside of Medicare 'Competitive' Bidding Program Before House Energy and Commerce Subcommittee 7Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 2Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 3Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 4Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 5Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 6Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 7Angioslide Commercializes in the U.S. First Device to Combine Balloon Angioplasty and Embolic Capture 8
(Date:8/1/2014)... August 01, 2014 A new study ... that carbohydrates may contribute to the development of colorectal ... the disease. The study was authored by Alberto Martin ... found to cause intestinal cells to multiply and create ... colorectal cancer. , “What’s interesting about this study,” ...
(Date:8/1/2014)... August 01, 2014 This week marks ... completes its 500th week of paying commissions to its ... was founded in January 2005 total $1,405,954,677.06. , MonaVie ... world. The company pays commissions in 18 different currencies, ... MYR, MXN, NZD, PLN, USD, SGD, KRW, TWD, THB ...
(Date:8/1/2014)... A leading dress supplier, Discount-Dress.com, explores a variety of ... any lady’s wardrobe fashionable and exciting. Recently, the company has ... To attract more people, it is now launching a special ... to 65% off. , “Summer is the season of short ... to our collection of ‘ 2014 summer short styles .’ ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 Transparency ... announced the addition of a comprehensive report on ... ‘Infusion System Market (Large Volume, Disposable, Syringe, Ambulatory ... Growth, Trends And Forecast, 2013 – 2019’ is ... http://www.transparencymarketresearch.com . , To begin with, the ...
(Date:8/1/2014)... CentraComm, a leading managed IT security ... the Pure Storage® Authorized Reseller program. , ... experience designed to meet the rigorous resiliency, scalability, ... diverse markets, and for a variety of high ... years. , The Pure Storage FlashArray was ...
Breaking Medicine News(10 mins):Health News:Carbs May Contribute to Colon Cancer 2Health News:MonaVie Records 500th Commission Week, Having Paid Out More Than $1.4B in Distributor Commissions 2Health News:Discount-Dress.com’s Top Trend Report: 2014 Summer Short Bridesmaid Dresses Now for Sale 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 2Health News:Transparency Market Research Adds Report on Global Infusion System Market to its Repository 3Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 2Health News:CentraComm Accepts Pure Storage Authorized Reseller Partner Invitation 3
... Royer Animal Health, LLC, a wholly owned subsidiary ... agreement with MWI Veterinary, Supply, Inc. (Nasdaq: ... MATRIX III CISPLATIN BEADS and R-GEL ... products provide veterinary professionals with localized treatment options for ...
... of many public services to head off infections , , ... swine flu cases in the United States has surpassed 100, ... to be the source of the outbreak -- braced for ... limit further infections in that country, where the virus is ...
... flu topping the agenda of,business around the world, global ... revealing the countries most at risk from an,influenza pandemic. ... Index (IPRI) consists of three categories:,Risk of Emergence, Risk ... list of countries most at risk and that require ...
... April 30 The Providence Service Corporation (Nasdaq: ... to report financial results for its first quarter ended March ... closes.Providence will hold a conference call at 11:00 a.m. EDT ... May 7, 2009, to discuss its financial results and corporate ...
... the world exercise in unison for 21st annual Project ACES ... the globe will walk, jog, bike or play games on ... (All Children Exercise Simultaneously) Day. This Youth Fitness ... College of Sports Medicine ,s Exercise is ...
... PREPARES FOR LAUNCH OF ,NEST-3, ACUTE ISCHEMIC STROKE CLINICAL ... of transcranial laser therapy (TLT) designed for the treatment ... onset, announced today that it has closed a $50 ... Pincus, a leading global private equity firm, to fund ...
Cached Medicine News:Health News:Royer Animal Health Enters Into Exclusive Agreement With MWI Veterinary Supply for U.S. Distribution of Next-Generation Therapeutics to Treat Cancer and Infections 2Health News:Swine Flu Infections Surpass 100 in U.S. 2Health News:Swine Flu Infections Surpass 100 in U.S. 3Health News:Swine Flu Infections Surpass 100 in U.S. 4Health News:Swine Flu Infections Surpass 100 in U.S. 5Health News:Swine Flu Infections Surpass 100 in U.S. 6Health News:Maplecroft Flu Pandemic Maps Reveal Countries Most at Risk 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 2Health News:Providence Service Corporation to Report First Quarter 2009 Results on Wednesday, May 6th After the Market Closes 3Health News:Youth to Fight Obesity With World's Largest Exercise Class 2Health News:Youth to Fight Obesity With World's Largest Exercise Class 3Health News:PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer 2Health News:PhotoThera Closes $50 Million Financing, Announces New President and Chief Executive Officer 3
Code-Ready defibrillator a defibrillator designed to provide clinicians with comprehensive support for resuscitation....
... The Escort Controller can be mounted ... pole or table top. The design ... the original controller, such as the pump ... detector, IV pump, and infusion system. ...
The ARK-730A initiates automatic measurement at the optimum measurement point. The ARK-730A maintains fogging throughout multiple measurements, saving total examination time....
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
Medicine Products: